KLCM Advisors’s Biogen BIIB Stock Holding History

KLCM Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-996	Closed	-$289K	–	99
2018 Q2	$289K	Sell	996 -1,200	-55%	-$337K	0.08%	67
2018 Q1	$601K	Hold	2,196	–	–	0.16%	48
2017 Q4	$700K	Hold	2,196	–	–	0.17%	48
2017 Q3	$688K	Hold	2,196	–	–	0.18%	44
2017 Q2	$596K	Hold	2,196	–	–	0.16%	44
2017 Q1	$600K	Hold	2,196	–	–	0.17%	40
2016 Q4	$623K	Buy	2,196 +1,500	+216%	+$445K	0.18%	38
2016 Q3	$218K	Buy	+696	New	+$206K	0.07%	67
2016 Q1	–	Sell	-696	Closed	-$213K	–	81
2015 Q4	$213K	Sell	696 -250	-26%	-$71.8K	0.08%	62
2015 Q3	$276K	Sell	946 -70	-7%	-$23.1K	0.1%	53
2015 Q2	$410K	Sell	1,016 -180	-15%	-$72.2K	0.1%	58
2015 Q1	$505K	Buy	1,196 +500	+72%	+$197K	0.14%	42
2014 Q4	$236K	Hold	696	–	–	0.06%	65
2014 Q3	$230K	Hold	696	–	–	0.06%	60
2014 Q2	$219K	Sell	696 -5	-0.7%	-$1.5K	0.05%	61
2014 Q1	$214K	Buy	+701	New	+$223K	0.06%	63

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

KLCM Advisors's BIIB Position: Q3 2018 in Review

KLCM Advisors sold out of Biogen (BIIB) in Q3 2018, closing a stake of 996 shares — an estimated $289K sold.

KLCM Advisors first reported a position in BIIB in Q1 2014 and held it in 16 quarters. The position peaked at $700K in Q4 2017. 1,146 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

KLCM Advisors reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
KLCM Advisors sold 996 Biogen shares in Q3 2018, an estimated $289K.
KLCM Advisors first reported a position in Biogen in Q1 2014 and held it in 16 quarters.
KLCM Advisors's Biogen position peaked at $700K in Q4 2017.
1,146 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on KLCM Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.